IP Verse

Methods For Increasing The Efficiency Of Homology Directed Repair (Hdr) In The Cellular Genome

PatentPatent Analysis

EP3559230

BRISTOL MYERS SQUIBB
Application Number
EP17832436A
Filing Date
Dec 20, 2017
Status
Granted And Under Opposition
Aug 4, 2023
Grant Date
Sep 6, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3781132B1
EP3818078B1
EP3631454B1

Bibliography

The patent EP3559230B1 was granted to Bristol Myers Squibb on Sep 6, 2023 following the initial filing on Dec 20, 2017 under the application number EP17832436A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

OETKEJun 5, 2024ADMISSIBLE
STRAWMANJun 5, 2024ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents